Research and Development

The Research and Development team at Targazyme Inc. focuses on advancing novel enzyme-based platform technologies to enhance the clinical efficacy and cost-effectiveness of various therapies, including cell therapy, immunotherapies for autoimmune diseases and cancer, stem cell transplantation, gene therapy, and regenerative medicine. This multidisciplinary team, comprised of leaders and scientists in immuno-oncology, CMC, and project management, drives innovation from concept through clinical implementation.